Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates.
To prevent important infectious diseases such as tuberculosis, malaria and HIV, vaccines inducing greater T cell responses are required. In this study, we investigated whether fusion of the M. tuberculosis antigen 85A to recently described adjuvant IMX313, a hybrid avian C4bp oligomerization domain,...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Public Library of Science
2012
|
| _version_ | 1797080737452654592 |
|---|---|
| author | Spencer, A Hill, F Honeycutt, J Cottingham, M Bregu, M Rollier, C Furze, J Draper, S Søgaard, K Gilbert, S Wyllie, D Hill, A |
| author_facet | Spencer, A Hill, F Honeycutt, J Cottingham, M Bregu, M Rollier, C Furze, J Draper, S Søgaard, K Gilbert, S Wyllie, D Hill, A |
| author_sort | Spencer, A |
| collection | OXFORD |
| description | To prevent important infectious diseases such as tuberculosis, malaria and HIV, vaccines inducing greater T cell responses are required. In this study, we investigated whether fusion of the M. tuberculosis antigen 85A to recently described adjuvant IMX313, a hybrid avian C4bp oligomerization domain, could increase T cell responses in pre-clinical vaccine model species. In mice, the fused antigen 85A showed consistent increases in CD4(+) and CD8(+) T cell responses after DNA and MVA vaccination. In rhesus macaques, higher IFN-(Gamma) responses were observed in animals vaccinated with MVA-Ag85A IMX313 after both primary and secondary immunizations. In both animal models, fusion to IMX313 induced a quantitative enhancement in the response without altering its quality: multifunctional cytokines were uniformly increased and differentiation into effector and memory T cell subsets was augmented rather than skewed. An extensive in vivo characterization suggests that IMX313 improves the initiation of immune responses as an increase in antigen 85A specific cells was observed as early as day 3 after vaccination. This report demonstrates that antigen multimerization using IMX313 is a simple and effective cross-species method to improve vaccine immunogenicity with potentially broad applicability. |
| first_indexed | 2024-03-07T01:04:25Z |
| format | Journal article |
| id | oxford-uuid:8ad44466-e47f-4258-a861-2a0107e8a0b6 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T01:04:25Z |
| publishDate | 2012 |
| publisher | Public Library of Science |
| record_format | dspace |
| spelling | oxford-uuid:8ad44466-e47f-4258-a861-2a0107e8a0b62022-03-26T22:34:15ZFusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8ad44466-e47f-4258-a861-2a0107e8a0b6EnglishSymplectic Elements at OxfordPublic Library of Science2012Spencer, AHill, FHoneycutt, JCottingham, MBregu, MRollier, CFurze, JDraper, SSøgaard, KGilbert, SWyllie, DHill, ATo prevent important infectious diseases such as tuberculosis, malaria and HIV, vaccines inducing greater T cell responses are required. In this study, we investigated whether fusion of the M. tuberculosis antigen 85A to recently described adjuvant IMX313, a hybrid avian C4bp oligomerization domain, could increase T cell responses in pre-clinical vaccine model species. In mice, the fused antigen 85A showed consistent increases in CD4(+) and CD8(+) T cell responses after DNA and MVA vaccination. In rhesus macaques, higher IFN-(Gamma) responses were observed in animals vaccinated with MVA-Ag85A IMX313 after both primary and secondary immunizations. In both animal models, fusion to IMX313 induced a quantitative enhancement in the response without altering its quality: multifunctional cytokines were uniformly increased and differentiation into effector and memory T cell subsets was augmented rather than skewed. An extensive in vivo characterization suggests that IMX313 improves the initiation of immune responses as an increase in antigen 85A specific cells was observed as early as day 3 after vaccination. This report demonstrates that antigen multimerization using IMX313 is a simple and effective cross-species method to improve vaccine immunogenicity with potentially broad applicability. |
| spellingShingle | Spencer, A Hill, F Honeycutt, J Cottingham, M Bregu, M Rollier, C Furze, J Draper, S Søgaard, K Gilbert, S Wyllie, D Hill, A Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates. |
| title | Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates. |
| title_full | Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates. |
| title_fullStr | Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates. |
| title_full_unstemmed | Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates. |
| title_short | Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates. |
| title_sort | fusion of the mycobacterium tuberculosis antigen 85a to an oligomerization domain enhances its immunogenicity in both mice and non human primates |
| work_keys_str_mv | AT spencera fusionofthemycobacteriumtuberculosisantigen85atoanoligomerizationdomainenhancesitsimmunogenicityinbothmiceandnonhumanprimates AT hillf fusionofthemycobacteriumtuberculosisantigen85atoanoligomerizationdomainenhancesitsimmunogenicityinbothmiceandnonhumanprimates AT honeycuttj fusionofthemycobacteriumtuberculosisantigen85atoanoligomerizationdomainenhancesitsimmunogenicityinbothmiceandnonhumanprimates AT cottinghamm fusionofthemycobacteriumtuberculosisantigen85atoanoligomerizationdomainenhancesitsimmunogenicityinbothmiceandnonhumanprimates AT bregum fusionofthemycobacteriumtuberculosisantigen85atoanoligomerizationdomainenhancesitsimmunogenicityinbothmiceandnonhumanprimates AT rollierc fusionofthemycobacteriumtuberculosisantigen85atoanoligomerizationdomainenhancesitsimmunogenicityinbothmiceandnonhumanprimates AT furzej fusionofthemycobacteriumtuberculosisantigen85atoanoligomerizationdomainenhancesitsimmunogenicityinbothmiceandnonhumanprimates AT drapers fusionofthemycobacteriumtuberculosisantigen85atoanoligomerizationdomainenhancesitsimmunogenicityinbothmiceandnonhumanprimates AT søgaardk fusionofthemycobacteriumtuberculosisantigen85atoanoligomerizationdomainenhancesitsimmunogenicityinbothmiceandnonhumanprimates AT gilberts fusionofthemycobacteriumtuberculosisantigen85atoanoligomerizationdomainenhancesitsimmunogenicityinbothmiceandnonhumanprimates AT wyllied fusionofthemycobacteriumtuberculosisantigen85atoanoligomerizationdomainenhancesitsimmunogenicityinbothmiceandnonhumanprimates AT hilla fusionofthemycobacteriumtuberculosisantigen85atoanoligomerizationdomainenhancesitsimmunogenicityinbothmiceandnonhumanprimates |